CARGO Therapeutics
has increased activity in mouse tumor models with all antigens and with antigen loss | CARGO Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
24 of 29
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Ocuphire Pharma
Investor Presentation
August 2023
preclinical data oral blocks | Ocuphire Pharma
Alkermes
Investor Day
March 2021
enhanced the anti tumor efficacy of in mouse tumors tumor growth inhibition overall survival combination with growth factor pathway inhibitors days vehicle complete responses days in combination with either or not shown resulted in enhanced tumor suppression and survival relative to groups similar results observed with a mouse surrogate of which is a selective inhibitor of the angiogenesis factor alkermes internal data on file the mouse of was used in mouse tumor model | Alkermes
DICE Therapeutics
Investor Presentation
March 2023
matches antibody activity in dice | DICE Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io